Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Revenue

Seoulin Bioscience had revenue of 20.80B KRW in the quarter ending June 30, 2026, with 28.23% growth. This brings the company's total for the last twelve months to 83.17B, up 17.13% year-over-year. In the year 2025, Seoulin Bioscience had annual revenue of 77.09B with 2.23% growth. That makes Seoulin Bioscience the 26,304th largest company in the world by revenue and 1,556th in South Korea.

• Revenue (ttm): 83.17B
• Revenue Growth: +17.13%
• P/S Ratio: 0.35
• Revenue / Employee: 735.98M
• Employees: 113
• Market Cap: 29.45B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Biotechnology Division 75.31B 97.6%
• HealthCare Sector 1.86B 2.4%

Fiscal year ended Dec 31, 2025 See the full Seoulin Bioscience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	77.09B	1.68B	2.23%
Dec 31, 2024	75.41B	-14.16B	-15.81%
Dec 31, 2023	89.57B	-15.14B	-14.46%
Dec 31, 2022	104.71B	24.17B	30.01%
Dec 31, 2021	80.54B	15.45B	23.74%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error